435 related articles for article (PubMed ID: 21471841)
1. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
[TBL] [Abstract][Full Text] [Related]
2. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 modulates the angiogenic phenotype of human cerebral arteriovenous malformation endothelial cells.
Stapleton CJ; Armstrong DL; Zidovetzki R; Liu CY; Giannotta SL; Hofman FM
Neurosurgery; 2011 May; 68(5):1342-53; discussion 1353. PubMed ID: 21307796
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
Gault J; Sain S; Hu LJ; Awad IA
Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
[TBL] [Abstract][Full Text] [Related]
5. YKL-40 can promote angiogenesis in sporadic cerebral cavernous malformation (CCM).
Shi Y; Song Y; Liu P; Li P
J Clin Neurosci; 2019 Jun; 64():220-226. PubMed ID: 30948312
[TBL] [Abstract][Full Text] [Related]
6. Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations.
Zhao Y; Tan YZ; Zhou LF; Wang HJ; Mao Y
Stroke; 2007 Apr; 38(4):1313-9. PubMed ID: 17322085
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cells from human cerebral aneurysm and arteriovenous malformation release ET-1 in response to vessel rupture.
Boscolo E; Pavesi G; Zampieri P; Conconi MT; Calore C; Scienza R; Parnigotto PP; Folin M
Int J Mol Med; 2006 Nov; 18(5):813-9. PubMed ID: 17016610
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PTEN promoter methylation in cerebral cavernous malformations.
Zhu Y; Wloch A; Wu Q; Peters C; Pagenstecher A; Bertalanffy H; Sure U
Stroke; 2009 Mar; 40(3):820-6. PubMed ID: 19118244
[TBL] [Abstract][Full Text] [Related]
9. Cerebral cavernous malformations: from genes to proteins to disease.
Cavalcanti DD; Kalani MY; Martirosyan NL; Eales J; Spetzler RF; Preul MC
J Neurosurg; 2012 Jan; 116(1):122-32. PubMed ID: 21962164
[TBL] [Abstract][Full Text] [Related]
10. Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes.
Schulz GB; Wieland E; Wüstehube-Lausch J; Boulday G; Moll I; Tournier-Lasserve E; Fischer A
Stroke; 2015 May; 46(5):1337-43. PubMed ID: 25791711
[TBL] [Abstract][Full Text] [Related]
11. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
[TBL] [Abstract][Full Text] [Related]
12. Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations.
Shenkar R; Shi C; Check IJ; Lipton HL; Awad IA
Neurosurgery; 2007 Oct; 61(4):693-702; discussion 702-3. PubMed ID: 17986930
[TBL] [Abstract][Full Text] [Related]
13. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase and tensin homolog in cerebral cavernous malformation: a potential role in pathological angiogenesis.
Zhu Y; Peters C; Hallier-Neelsen M; Miller D; Pagenstecher A; Bertalanffy H; Sure U
J Neurosurg; 2009 Mar; 110(3):530-9. PubMed ID: 19061355
[TBL] [Abstract][Full Text] [Related]
15. Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells.
Jabbour MN; Elder JB; Samuelson CG; Khashabi S; Hofman FM; Giannotta SL; Liu CY
Neurosurgery; 2009 Jan; 64(1):139-46; discussion 146-8. PubMed ID: 19145162
[TBL] [Abstract][Full Text] [Related]
16. Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor.
Jung KH; Chu K; Jeong SW; Park HK; Bae HJ; Yoon BW
Arch Neurol; 2003 Nov; 60(11):1613-8. PubMed ID: 14623736
[TBL] [Abstract][Full Text] [Related]
17. Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.
Detter MR; Snellings DA; Marchuk DA
Circ Res; 2018 Oct; 123(10):1143-1151. PubMed ID: 30359189
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Cell-Pericyte Interactions in the Pathogenesis of Cerebral Cavernous Malformations (CCMs).
Min W; Zhou JH
Cold Spring Harb Perspect Med; 2023 Mar; 13(3):. PubMed ID: 35667709
[TBL] [Abstract][Full Text] [Related]
19. Study of CCM Microvascular Endothelial Phenotype by an In Vitro Tubule Differentiation Model.
Delle Monache S; Retta SF
Methods Mol Biol; 2020; 2152():371-375. PubMed ID: 32524565
[TBL] [Abstract][Full Text] [Related]
20. GLYOXALASE I A111E, PARAOXONASE 1 Q192R AND L55M POLYMORPHISMS IN ITALIAN PATIENTS WITH SPORADIC CEREBRAL CAVERNOUS MALFORMATIONS: A PILOT STUDY.
Rinaldi C; Bramanti P; Famà A; Scimone C; Donato L; Antognelli C; Alafaci C; Tomasello F; D'Angelo R; Sidoti A
J Biol Regul Homeost Agents; 2015; 29(2):493-500. PubMed ID: 26122242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
